{"sourcedb":"DevicePMAs@therightstef","sourceid":"P020035_S002","text":"Approval for various labeling changes and ergonomic changes to the device.  The device, as modified, will be marketed under the trade name x-site suture-mediated closure device and is indicated for ??the percutaneous delivery of suture for closing the common femoral artery access site of patients who have undergone diagnostic or interventional coronary catheterization procedures using sheaths less than or equal to 6 fr.  The x-site suture-mediated closure device is intended to reduce the time to h0mostasis, time to ambulation (100 feet), and time to dischargeability in patients who have undergone diagnostic or interventional coronary catheterization procedures without complicating clinical conditions, including those receiving glycoprotein iib/iiia inhibitors.?","project":"consensus_PMA_Age_Indications"}